DBV Technologies S.A. (DBVT) stock
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 6/30
$9.99−0.28 (-2.73%)
Close on Nov 17, 2026Market cap $628.15MP/E –Yield –
DBV Technologies total assets
Total assets on the balance sheet at the end of each period.
DBV Technologies's total assets was $215.40M at Sep 30, 2026. For fiscal 2025 it was $233.70M, up 255.9% from the year before. The highest annual figure on record is $272.25M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $233.70M | +255.9% |
| FY2024 | Dec 31, 2024 | $65.66M | -64.1% |
| FY2023 | Dec 31, 2023 | $182.99M | -25.8% |
| FY2022 | Dec 31, 2022 | $246.52M | +68.0% |
| FY2021 | Dec 31, 2021 | $146.72M | -46.1% |
| FY2020 | Dec 31, 2020 | $272.25M | +0.2% |
| FY2019 | Dec 31, 2019 | $271.73M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $215.40M | +94.9% |
| Q2 FY2026 | Jun 30, 2026 | $223.20M | +55.6% |
| Q1 FY2026 | Mar 31, 2026 | $266.40M | +426.9% |
| Q4 FY2025 | Dec 31, 2025 | $233.70M | +255.9% |
| Q3 FY2025 | Sep 30, 2025 | $110.50M | +18.7% |
| Q2 FY2025 | Jun 30, 2025 | $143.43M | +25.6% |
| Q1 FY2025 | Mar 31, 2025 | $50.56M | -65.3% |
| Q4 FY2024 | Dec 31, 2024 | $65.66M | -64.1% |
| Q3 FY2024 | Sep 30, 2024 | $93.06M | -51.0% |
| Q2 FY2024 | Jun 30, 2024 | $114.19M | -47.5% |
| Q1 FY2024 | Mar 31, 2024 | $145.90M | -37.4% |
| Q4 FY2023 | Dec 31, 2023 | $182.99M | -25.8% |
| Q3 FY2023 | Sep 30, 2023 | $189.78M | -23.5% |
| Q2 FY2023 | Jun 30, 2023 | $217.52M | -23.7% |
| Q1 FY2023 | Mar 31, 2023 | $232.93M | +98.1% |
| Q4 FY2022 | Dec 31, 2022 | $246.52M | +68.0% |
| Q3 FY2022 | Sep 30, 2022 | $248.12M | +45.2% |
| Q2 FY2022 | Jun 30, 2022 | $284.98M | +42.1% |
| Q1 FY2022 | Mar 31, 2022 | $117.58M | -46.9% |
| Q4 FY2021 | Dec 31, 2021 | $146.72M | -46.1% |
| Q3 FY2021 | Sep 30, 2021 | $170.92M | -37.1% |
| Q2 FY2021 | Jun 30, 2021 | $200.58M | – |
| Q1 FY2021 | Mar 31, 2021 | $221.41M | – |
| Q4 FY2020 | Dec 31, 2020 | $272.25M | – |
| Q4 FY2019 | Dec 31, 2019 | $271.73M | – |
See a number that looks wrong?